Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Core Insights - Profusa, Inc. has restructured its Senior Secured Convertible Notes to enhance repayment flexibility and reduce shareholder dilution [1][2] - The conversion floor price has been increased from $0.10 to $0.35, and mandatory amortization payments have been eliminated [2] - The final payment of the notes is due 18 months after issuance, with mandatory payments related to the ELOC increasing from 33% to 50% for shares issued under new registration statements [2] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors for continuous monitoring of biochemistry [4] - The company aims to provide personalized biochemical signatures through its long-lasting, injectable biosensors and intelligent data platform [4] - Profusa is led by experienced management and a world-class board, emphasizing its commitment to delivering actionable medical-grade data [4] Management Statements - The CFO of Profusa highlighted the importance of the restructuring in reducing debt and share price dilution, aiming to enhance shareholder value [2] - The CEO expressed excitement about the company's progress towards revenue and the balance sheet restructuring, indicating a focus on accelerating initiatives and developing partnerships [3]